Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis
- PMID: 12387654
- DOI: 10.1001/jama.288.16.2015
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis
Abstract
Context: It has been suggested that total blood homocysteine concentrations are associated with the risk of ischemic heart disease (IHD) and stroke.
Objective: To assess the relationship of homocysteine concentrations with vascular disease risk.
Data sources: MEDLINE was searched for articles published from January 1966 to January 1999. Relevant studies were identified by systematic searches of the literature for all reported observational studies of associations between IHD or stroke risk and homocysteine concentrations. Additional studies were identified by a hand search of references of original articles or review articles and by personal communication with relevant investigators.
Study selection: Studies were included if they had data available by January 1999 on total blood homocysteine concentrations, sex, and age at event. Studies were excluded if they measured only blood concentrations of free homocysteine or of homocysteine after a methionine-loading test or if relevant clinical data were unavailable or incomplete.
Data extraction: Data from 30 prospective or retrospective studies involving a total of 5073 IHD events and 1113 stroke events were included in a meta-analysis of individual participant data, with allowance made for differences between studies, for confounding by known cardiovascular risk factors, and for regression dilution bias. Combined odds ratios (ORs) for the association of IHD and stroke with blood homocysteine concentrations were obtained by using conditional logistic regression.
Data synthesis: Stronger associations were observed in retrospective studies of homocysteine measured in blood collected after the onset of disease than in prospective studies among individuals who had no history of cardiovascular disease when blood was collected. After adjustment for known cardiovascular risk factors and regression dilution bias in the prospective studies, a 25% lower usual (corrected for regression dilution bias) homocysteine level (about 3 micromol/L [0.41 mg/L]) was associated with an 11% (OR, 0.89; 95% confidence interval [CI], 0.83-0.96) lower IHD risk and 19% (OR, 0.81; 95% CI, 0.69-0.95) lower stroke risk.
Conclusions: This meta-analysis of observational studies suggests that elevated homocysteine is at most a modest independent predictor of IHD and stroke risk in healthy populations. Studies of the impact on disease risk of genetic variants that affect blood homocysteine concentrations will help determine whether homocysteine is causally related to vascular disease, as may large randomized trials of the effects on IHD and stroke of vitamin supplementation to lower blood homocysteine concentrations.
Comment in
-
Homocysteine and coronary heart disease: how great is the hazard?JAMA. 2002 Oct 23-30;288(16):2042-3. doi: 10.1001/jama.288.16.2042. JAMA. 2002. PMID: 12387658 No abstract available.
-
Review: elevated homocysteine levels are modestly associated with increased ischemic heart disease and stroke risk.ACP J Club. 2003 May-Jun;138(3):78. ACP J Club. 2003. PMID: 12725633 No abstract available.
Similar articles
-
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.Arch Intern Med. 1998 Apr 27;158(8):862-7. doi: 10.1001/archinte.158.8.862. Arch Intern Med. 1998. PMID: 9570171
-
Homocysteine, renal function, and risk of cardiovascular disease.Kidney Int Suppl. 2003 May;(84):S131-3. doi: 10.1046/j.1523-1755.63.s84.7.x. Kidney Int Suppl. 2003. PMID: 12694328
-
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.JAMA. 2005 Oct 12;294(14):1799-809. doi: 10.1001/jama.294.14.1799. JAMA. 2005. PMID: 16219884
-
Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.Semin Thromb Hemost. 2000;26(3):341-8. doi: 10.1055/s-2000-8101. Semin Thromb Hemost. 2000. PMID: 11011852 Review.
-
Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.Curr Opin Clin Nutr Metab Care. 2007 Jan;10(1):32-9. doi: 10.1097/MCO.0b013e328011aa71. Curr Opin Clin Nutr Metab Care. 2007. PMID: 17143052 Review.
Cited by
-
Identifying hypoxia in a newborn piglet model using urinary NMR metabolomic profiling.PLoS One. 2013 May 31;8(5):e65035. doi: 10.1371/journal.pone.0065035. Print 2013. PLoS One. 2013. PMID: 23741447 Free PMC article.
-
The Implication of a Polymorphism in the Methylenetetrahydrofolate Reductase Gene in Homocysteine Metabolism and Related Civilisation Diseases.Int J Mol Sci. 2023 Dec 22;25(1):193. doi: 10.3390/ijms25010193. Int J Mol Sci. 2023. PMID: 38203363 Free PMC article. Review.
-
Vitamin B6, B12, and Folate's Influence on Neural Networks in the UK Biobank Cohort.Nutrients. 2024 Jun 27;16(13):2050. doi: 10.3390/nu16132050. Nutrients. 2024. PMID: 38999798 Free PMC article.
-
The Effects of Medicinal Plants and Bioactive Natural Compounds on Homocysteine.Molecules. 2021 May 21;26(11):3081. doi: 10.3390/molecules26113081. Molecules. 2021. PMID: 34064073 Free PMC article. Review.
-
Increased serum methylmalonic acid levels were associated with the presence of cardiovascular diseases.Front Cardiovasc Med. 2022 Oct 10;9:966543. doi: 10.3389/fcvm.2022.966543. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36299874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical